These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27924722)

  • 41. [Diabetic nephropathy].
    Agardh CD
    Nord Med; 1992; 107(8-9):215-6. PubMed ID: 1408727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
    Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
    J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
    Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
    J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.
    Vitova L; Tuma Z; Moravec J; Kvapil M; Matejovic M; Mares J
    BMC Nephrol; 2017 Mar; 18(1):112. PubMed ID: 28359252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel urinary biomarkers in pre-diabetic nephropathy.
    Garg V; Kumar M; Mahapatra HS; Chitkara A; Gadpayle AK; Sekhar V
    Clin Exp Nephrol; 2015 Oct; 19(5):895-900. PubMed ID: 25634253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea.
    Kim DM; Ahn CW; Park JS; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S169-72. PubMed ID: 15563971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The practical assessment of micro-albuminuria as a marker for beginning diabetic nephropathy in: which urine sampling method?].
    Caduff F; Spinas GA; Engler H; Achermann HR; Berger W
    Schweiz Med Wochenschr; 1991 Mar; 121(10):324-31. PubMed ID: 2028235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary proteomics for early diagnosis in diabetic nephropathy.
    Zürbig P; Jerums G; Hovind P; Macisaac RJ; Mischak H; Nielsen SE; Panagiotopoulos S; Persson F; Rossing P
    Diabetes; 2012 Dec; 61(12):3304-13. PubMed ID: 22872235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria.
    Hutchison AS; O'Reilly DS; MacCuish AC
    Clin Chem; 1988 Oct; 34(10):2019-21. PubMed ID: 3168213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
    Tofik R; Torffvit O; Rippe B; Bakoush O
    Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST; Tseng ST
    Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
    Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
    Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial factors in diabetic nephropathy: an offspring study.
    Agius E; Attard G; Shakespeare L; Clark P; Vidya MA; Hattersley AT; Fava S
    Diabet Med; 2006 Mar; 23(3):331-4. PubMed ID: 16492220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early urinary and plasma biomarkers for experimental diabetic nephropathy.
    Alter ML; Kretschmer A; Von Websky K; Tsuprykov O; Reichetzeder C; Simon A; Stasch JP; Hocher B
    Clin Lab; 2012; 58(7-8):659-71. PubMed ID: 22997966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
    Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
    Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary lysophopholipids are increased in diabetic patients with nephropathy.
    Saulnier-Blache JS; Feigerlova E; Halimi JM; Gourdy P; Roussel R; Guerci B; Dupuy A; Bertrand-Michel J; Bascands JL; Hadjadj S; Schanstra JP
    J Diabetes Complications; 2017 Jul; 31(7):1103-1108. PubMed ID: 28506691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteinuria in diabetic nephropathy: treatment and evolution.
    Campbell RC; Ruggenenti P; Remuzzi G
    Curr Diab Rep; 2003 Dec; 3(6):497-504. PubMed ID: 14611747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship between haemoglobin level and type 1 diabetic nephropathy in Han patients in Anhui, China.
    Jiang J; Lan L; Zhou X; Peng L; Ren W
    Intern Med J; 2018 Jul; 48(7):830-835. PubMed ID: 29460412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
    Andrésdóttir G; Bakker SJ; Hansen HP; Parving HH; Rossing P
    Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.